Dana-Farber/Boston Children's Cancer and Blood Disorders Center

US News Names Dana-Farber Boston Children’s #1

Mayor Walsh Reflects on his Childhood Cancer before Audience of Cancer Survivors

Global Health Statistics

Where We Work

Cancer Can’t Stop this Dorchester Teenager

In Cancer’s Aftermath, Young Adults Find Support from Each Other

A Young Cancer Patient’s Take on “The Fault in Our Stars”

Exploring Scorpion Venom’s Potential to Treat Cancer

Malignant Rhabdoid Tumor

Just 16, Karina Moreira Battles Cancer in her Own Style

Researchers Say Study Underscores Importance of Newborn Screening for “Bubble Boy” Disease

University Rallies for Student Fighting Cancer

In Children with Cancer, Navy SEALS Find “Like-Minded” Warriors

Training Community-Based Pediatricians in Palliative Care

Other Pediatric Conditions We Treat

Preventing Infections in Outpatients Caring for Central Lines at Home

Study Calls for Revisiting Guidelines for Screening Childhood Cancer Survivors at Risk of Congestive Heart Failure

Tips for Primary Care Physicians Treating Survivors of Childhood Cancer

Questions to Ask When Your Child Finishes Cancer Treatment

What to Do if Your Child Relapses

As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond

More Children Are Developing Cancer But Fewer Are Dying

A patient and doctor team come full circle

Five Ways to Support Families Dealing with Childhood Cancer

Determined to Get Back in the Game

Cancer Diagnosis Cant Shake These First-time Parents

New Research Shows Promise for Pediatric Brain Tumor Treatment

Boston Mayor Marty Walsh Proud to be a Cancer Survivor

Common Genetic Variations May Contribute to Treatment-related Cognitive Problems in Children with Leukemia

Stem Cell Transplant without Radiation or Chemotherapy Pre-treatment Shows Promise for Rare Bone Marrow Failure

Pediatric Neuro-Oncology Clinical Fellowship

The Bad Disease: Inside Egypt’s Children’s Cancer Hospital

Unlocking the Secrets of Pediatric Cancers can Help Doctors Treat Children and Adults

Nine-year-old with Brain Tumor gets to Finish Concert with Friends

Q&A with David Williams

Family of Infant with AML Goes Home for Christmas

Pathology in Global Health

Gene Therapy for “Bubble Boy” Disease Appears to be Effective and Safe

Blood Work

A Child Saved Becomes a Teen Hunting for Cures

Parents of Late Quincy Teen Watch “Fault in Our Stars” with Her Providers

Liberia’s Response to Ebola

David G. Nathan, MD, Wins Boston Children’s Hospital Inaugural Lifetime Impact Award

Researchers Take New Approach to Stop ‘Most Wanted’ Cancer Protein

Imaging Captures How Blood Stem Cells Take Root

Cancer Care for the Developing World

Boston Hospitals Pave Way for Precision Medicine

Five Things Pediatricians Should Know About Children Who’ve Had Cancer

Palliative Care Eases the Burden of Serious Illness

The Late Effects of Childhood Cancer

Survivorship Care: David B. Perini Jr. Quality of Life Clinic

Transition Off Therapy: Care After Pediatric Cancer Treatment

Your Primary Team

Glioma in Children

Phase I Trial of Immunotherapy Opens for Children with Relapsed or Treatment-resistant Leukemia

Discussing Child’s Cancer Prognosis More Likely to Produce Peace of Mind and Decrease Anxiety in Parents

U.S. News Names Dana-Farber Boston Children’s #1 Pediatric Cancer Program

Philippines

Ethiopia

Rwanda

Promising Drug Target Identified in Medulloblastoma

Relapsed or Refractory Neuroblastoma

Guatemala

MATCHing precision medicine to all kids with cancer

Fishing for new leads in rare mucosal melanoma

In zebrafish, a way to find new cancer therapies, targeting tumor promoters

Solving the DIPG puzzle a single cell at a time

Probing the brain’s earliest development, with a detour into rare childhood cancers

A bold strategy to enhance CAR T-cell therapies, capable of targeting DIPG and other tough-to-treat cancers

Zeroing in on the fetal-to-adult hemoglobin switch and a new way to combat sickle cell disease

A breakthrough in our understanding of how red blood cells develop

Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma

Dulling cancer therapy’s double-edged sword: A new way to block tumor recurrence

New gene therapy strategy for sickle cell disease shows early promise in humans

Adrenal Tumors

Carcinoid Tumors

Carney Triad

Multiple Endocrine Neoplasia

Neuroendocrine Tumors

Paraganglioma/Pheochromocytoma

Tumors of the Pancreas

How I Live

Boston Children’s Hospital to receive $1.5M to initiate basic work to expand gene therapy treatment of sickle cell disease into developing countries

CRISPR-Cas9 screen opens new targets for Ewing sarcoma, other childhood cancers

Current Region-Wide Initiatives

Multi-center study led by Dana-Farber/Boston Children's contributes to FDA approval of a new treatment for acute lymphoblastic leukemia

Request an Appointment

Refer a Patient

Find Doctor Details

Find Doctor Results

Clinical Trials Results

Clinical Trials Detail

Bone and Soft Tissue Tumors Program

Neuroblastoma Program

Blood Disorders Center

Retinoblastoma Program

Leukemia, Lymphoma, and Histiocytosis

Brain Tumors

Atypical Teratoid Rhabdoid Tumor (ATRT)

Astrocytoma

Pilocytic Astrocytoma in Children

Choroid Plexus Tumor

Diffuse Intrinsic Pontine Glioma (DIPG)

Ependymoma

Ganglioglioma

Germ cell tumors of the brain

Glioblastoma multiforme

Low Grade Glioma

Medulloblastoma

Oligodendroglioma

Optic Nerve (Pathway) Glioma in Children

Primitive Neuroectodermal Tumors (PNET)

Tectal gliomas

Thalamic or hypothalamic astrocytoma

Craniopharyngioma

Gliomatosis cerebri

Meningioma

Pleomorphic xanthoastrocytoma

Adamantinoma

Alveolar Soft Part Sarcoma

Peripheral nerve sheath tumor (neurofibrosarcoma)

Retinoblastoma

Rhabdomyosarcoma

Schwannoma (Neurilemoma)

Hematologic Malignancy Center

Rare Tumors Program

General Inquiries

Medulloblastoma Program

Glioma Program

Pediatric Cancer Genetic Risk Program

Pediatric Advanced Care Team

Pediatric Fertility Preservation Program

Psychosocial Services

Precision Medicine

Immunotherapy for Children

Brain Tumor Survivorship

Williams honored for Outstanding Achievement by ASGCT

International Gene Therapy Trial Launched at Children's Hospital Boston

Potential gene therapy approach to sickle cell disease highlighted at ASH

The American Society of Hematology Elects New Leadership

Alex's Lemonade Stand Foundation awards $1.75 million grant to Dana-Farber Boston Children's Cancer and Blood Disorders Center

National Academy of Sciences honors Dana-Farber Boston Children's Cancer and Blood Disorders Center's Orkin

Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patients

Justin Bieber Dream Date Shines Light on Rare Pediatric Cancer

American Association for Cancer Research honors D'Andrea

Key mutations discovered for most common childhood brain cancer

Dana-Farber/Children's Hospital Cancer Center establishes training program with Egypt Cancer Network and Children's Cancer Hospital Egypt

Intensified chemotherapy shows promise for children with very high-risk form of leukemia

Chondroblastoma

Brain Tumor Overview

What's in a name

A new, faster route for pediatric clinical trials

Revealing new mutations in pediatric myelodysplastic syndromes

Delays in diagnosis worsen outlook for minority, uninsured pediatric retinoblastoma patients, study finds

Majority of children readmitted to hospital following transplant

Building a community around vascular anomalies research

Scientists find mutation driving pediatric brain tumors

Dana Farber Boston Children s Cancer and Blood Disorders Center launches new website

Seminar: Causes and effects of the shortage of oncology drugs

The High Price of Tanning

Optimism about Pediatric Cancer Care

Teaming with our twin in India, to take on hemophilia

Overcoming Drew’s blood disorder, together

Research registry reveals new mutations in rare childhood blood disorders

Summer Fun for Kids with Cancer

New Diller study

Dangers of Tanning Beds

Gene therapy’s time seems to have come

Childhood Cancer Awareness Month

About-Us

Media Relations Policy

Television Studio

Gene Therapy Trial for Bubble Boy Syndrome

New Procedures Help Pediatric Cancer Patients With Future Fertility

Haematopoietic Stem Cell Transplants

Teenager Raises Thousands to Help Children with Vascular Anomalies

Five Things Parents of Children with Cancer Should Know

After Cancer Fertility Is Often Within Reach

The Survivorship Care Gap: After Childhood and AYA Cancers, How to Keep Survivors in Follow-Up Care

How to Help Your Child if a Classmate Has Cancer

Interventional Radiology

Directions and Parking

Niña Batalla por Garnale al Cancer

The Gospel of Calle

Newly Discovered Gene Regulator Could Precisely Target Sickle Cell Disease

Survivors of Pediatric Brain Tumors Share a Special Bond

Pediatric Melanoma

Dr Joanne Wolfe wins American Cancer Society Pathfinder Award

Martin Walsh's Childhood Marked by Cancer Fight

Nasopharyngeal Carcinoma

Thyroid Carcinoma

Adrenocortical Carcinoma

Patricia Branowicki Elected to American Academy of Nursing

'Care Bundle’ Prevents Central Line-Associated Bloodstream Infections in Ambulatory Pediatric Cancer Patients

Young Warrior Shares His Story

Dana-Farber/Boston Children’s physicians among Boston Magazine’s Top Doctors 2013

International gene therapy trial for bubble boy disease shows promising early results

Rare cause of anemia in newborns often overlooked

Less Painful Drug Delivery for Pediatric Leukemia Patients is Safe, Effective, Research Suggests

Discovery holds promise for bubble boy patients

Gene therapy keeps bubble boy disease at bay in 8 children

My Sportsman: Nebraska Fan Jack Hoffman

Bubble Boy Disease Could Have a Cure

Mom, Son Battle Cancer Together with Inspiration and Teamwork

Study: Eating Nuts in Pregnancy May Lower Child’s Allergy Risk

Kidney Tumor Program

Gisele Bundchen Visits Young Malden Girl Battling Cancer

Antipsychotic Drug Exhibits Cancer-Fighting Properties

Forbes Names Scientist One of “30 under 30” to Watch

Fertility After Treatment for Childhood Cancer

Fertility Among Survivors of Childhood Cancer

Lives Less Ordinary

Mutation Discovery May Improve Treatment for Rare Brain Tumor Type

Perseverance On and Off the High School Basketball Court

Sick Kids Need Faster Drug Testing

Long-term Survival Among Patients with Most Common Childhood Brain Tumor is High

Normal Enzyme Aids a Mutant One to Fuel Blood Cancer’s Growth

Alisha’s Strength Drives Cancer Fight

Hope Grows for Sickle Cell Disease Patients

Vermont Girl Gets Second Bone Marrow Transplant

Sick Vt. Kids Highlight Need for Bone Marrow Donors

Attleboro Police Make Room for a Middleborough Boy with Cancer

NH Boy Adopted from Ethiopia Finds Bone Marrow Match with African Siblings

Scientists Find Potential Drug Targets in Deadly Pediatric Brain Tumors

Caring for a Central Line (Spanish)

Caring for a Central Line (Arabic)

Gene Linked to Pediatric Kidney Cancer Suggests New Strategies for Kidney Regeneration

Physician Advocates for Palliative Care Bill on Beacon Hill

High School Athlete Shows Strength On-field and Off

Medical Education to Fight Global Cancer

Children with Low-grade Glioma Enjoy Long-term Survival

Nurse Lauded for Efforts with Patients

Siblings Arrive from Ethiopia to Try and Save Brother's Life

Researchers Uncover Link Between Down Syndrome and Childhood Leukemia

Billerica High Cell-out to Help Boy with Leukemia Worthy of a Standing ‘O’

Bluebird Bio Advances Experimental Drug for Genetic Brain Disorder

Using a Nasogastric Tube

Caring for a Central Line at Home (English)

Working with Adult Survivors of Childhood Cancers

Dana-Farber/Boston Children's launches first DIPG Brain Tumor Consortium

Dana-Farber/Boston Children’s Hojun Li named a 2020 Scholar Award Recipient by the American Society of Hematology

Dana-Farber/Boston Children’s faculty named 2020 Top Doctors

CAR T-Cell Therapy

CAR T-Cell Therapy for Pediatric Leukemia

CAR T-Cell Therapy for Pediatric Lymphoma

The CAR T-Cell Therapy Team

Stuart Orkin named 2020 King Faisal Prize Laureate in Medicine

Day One Talk Videos

Therapy Directed Against Platelets Does Not Significantly Reduce Painful Crises in Sickle Cell Disease

Studies highlight new drug targets or compounds for acute myeloid leukemia

Special holiday concert features young violinist and surgeon who removed her brain tumor

More than two-thirds of teen and young adult cancer patients facing end of life use aggressive measures

Genetic Sequencing Can Help Guide Treatment in Children with Solid Tumors

Genetic Cause Identified in Rare Pediatric Brain Tumor

In Precision Medicine, Pioneering Young Patient Teaches Veteran Doctor

Childhood leukemia patients from high-poverty areas more likely to suffer early relapse

Study explores how high-fat diet influences colon cancer

Amazing Allison: A young 'pioneer' and the Boston doctors who saved her

Armenia

The Coalition for Pediatric Medical Research: Recommended Pediatric Priorities for the Cancer Moonshot Initiative

Making a difference: Treating sickle cell disease in Liberia

Young adult survivors of childhood cancer report

Evidence suggesting link between cancer and light therapy

Q & A: Making sense of new research on possible link between phototherapy for newborn jaundice and cancer

Brave boy donates bone marrow to sister fighting leukemia

Science commentary explores ways to pay for success in gene therapy

Genetic treatments for sickle cell

The Osteosarcoma Institute to fund clinical trial in recurrent osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Shimamura named recipient of the 2020 Frank A. Oski Memorial Lectureship from ASPHO

Count Me In launches Osteosarcoma Project

Hass-Kogan receives funding for new DIPG-specific research project from Defeat DIPG and ChadTough

Dana-Farber/Boston Children’s receives $200,000 grant from Hyundai Hope On Wheels to support COVID-19 testing

Bauer earns Outstanding New Investigator Award from ASGCT

Massive study reveals how 'hypermutated' malignant brain tumors with many mutations escape chemotherapy and immunotherapy

2020 Harrington Prize awarded to Dr. Stuart H. Orkin

Pioneering a ‘Staple’ Approach for Treating COVID-19

Pediatric neurosurgeon Lissa Baird, MD, joins Dana-Farber/Boston Children’s

Population-based registry data identifies novel cancer patterns in families of childhood cancer patients

We’ve known for 50 years what causes sickle cell disease. Where’s the cure?

Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma

Dana-Farber Boston Children’s remains nation’s #1 pediatric cancer program

Rotationplasty

What to Expect During MIBG Treatment

Make children’s cancer research a ‘moonshot’ priority

How drug companies use gifts and internships to reach valuable hemophilia patients

Transplants from any donor without toxicity

Scott Armstrong, MD, PhD, recognized by ISSCR for contributions to basic and translational research in hematological disorders

Dana-Farber/Boston Children's Brian D. Crompton, MD, awarded research grant by the Go4theGoal Foundation

Researchers at Dana-Farber/Boston Children's and UMass Medical School optimize gene editing for sickle cell disease and beta thalassemia

Giving Medications Safely at Home (English)

Giving Medications Safely at Home (Spanish)

Giving Medications Safely at Home (Arabic)

Children with cancer wait an average of 6.5 years longer than adults to access new targeted drugs, finds study at Dana-Farber/Boston Children’s

Lynda M. Vrooman to present findings from Dana-Farber/Boston Children’s clinical trial that led to FDA approval of novel drug for treatment of ALL in young patients

Team led by Dana-Farber/Boston Children’s Kimberly Stegmaier receives SU2C Sharp Award from Stand Up To Cancer

Katherine E. Warren, MD, joins Dana-Farber/Boston Children’s as Clinical Director for Pediatric Neuro-Oncology

Dana-Farber/Boston Children's nation’s #1 pediatric cancer program

Leonard Zon, MD, honored by the American Society of Hematology for Outstanding Mentorship

Egypt

What Are the Differences Between Adult and Childhood Brain Tumors?

What Specialists Does a Child See When Diagnosed with Cancer?

What You Need to Know for Life After Childhood Cancer Treatment

Reducing the toxicity of cancer treatment

Mahra Beats Cancer and Avoids Amputation

Infographic-four-things-you-need-to-know-about-childhood-cancer

Google Hangout

Haiti

Mexico

Disparities in Outcomes for Children with Rare Eye Cancer Suggest Unequal Access to Primary Care

Study Uses Gene Editing to Take Brakes Off Lab-based Red Blood Cell Production

Precision Medicine Infographic

Clinical Trials for Relapsed Cancer

Children with Childhood Leukemia Benefit from Prophylactic Antibiotics

Early Gene Therapy Results in Wiskott-Aldrich Syndrome Promising

“Stapled” antimicrobial peptides could combat antibiotic resistance

Amazon surprises Dana-Farber/Boston Children’s with a $500,000 donation during Childhood Cancer Awareness Month

Stem Cell Transplant

Dana-Farber/Boston Children's Faculty Named 2021 Top Doctors

Stuart H. Orkin Receives the 2021 ISSCR Tobias Lecture Award

In landmark study, an arthritis drug appears to prevent deadly acute graft-versus-host disease after bone marrow transplant

Targeted therapy for children with leukemia can provide substantial benefit, study finds

Stuart Orkin receives $500,000 Gruber Genetics Prize for his groundbreaking research on the genetics of inherited blood disorders

Childhood cancer survivors, providers satisfied with video visits for long-term follow-up

Patriots’ Nate Solder seeks normalcy after hellish year

Childhood cancer deaths: Brain cancer overtakes leukemia as top cause

Finally, hope for a young patient with CGD

Germ Cell Tumors

Ovarian Tumors in Children and Teens

Fighting genetic disease with help of HIV virus

Research into basic workings of immune system points to way of improving therapies for cancer and chronic infection

Scientists tackle DIPG, a lethal childhood brain cancer

Testicular Tumors

Gene therapy offers hope for treatment of sickle cell anemia

Boston Children’s hires a chief scientific officer

The role of early phase clinical trials in end-of-life care for children

Intimate photos show young Guatemalan boy’s journey through cancer

Os pequenos herois que venceram o cancer

Children with Down syndrome and acute lymphoblastic leukemia

Deaths in cancer trials remain mystery for promising therapy

Pioneering doctor reflects on gene therapy’s trajectory

Sickle cell disease: An unpredictable adversary

Applying local knowledge

Germinoma

Gene therapy trial gives Coopersville toddler second chance at life

Alex’s Lemonade Stand Foundation awards $4.95 million to Dana-Farber/Boston Children’s researchers as part of its Crazy 8 Initiative to advance pediatric cancer research

Four Things on the Horizon

Gene Editing Study Reveals Possible Achilles Heel of Sickle Cell Disease

Almost One Third of Families of Children with Cancer Have Unmet Basic Needs During Treatment

Second Opinions

Dominican Republic

Stuart Orkin and Daniel Bauer receive funding for sickle cell disease research from the Doris Duke Charitable Foundation

Gene therapy trial wrenches families as one child’s death saves another

Biden should take a note from the original moonshot: Focus on just one cancer

Finding a cure wouldn’t mean we’ve defeated cancer

Outpatient bloodstream infections costly for pediatric stem cell transplant and cancer patients

BCL11A-based gene therapy for sickle cell disease passes key preclinical test

Discovery offers prospect of shorter treatment and cure for chronic myelogenous leukemia

Precision medicine advances pediatric brain tumor diagnosis and treatment

In overhauling Obamacare the details matter

It’s not an even playing field

Travel dreams fulfilled for 9-year-old with terminal cancer

Stem-cell-derived cells flag possible new treatment for Diamond-Blackfan anemia

Angiosarcoma

From moving mountains to climbing mountains, Fulton native seeks to redefine ‘possible’

The Lifesaving Care Act

Martial arts instructors volunteer with kids fighting cancer

One boy’s cure raises hopes and questions about gene therapy for sickle cell disease

How a child made scientists think of cytokines as knobs instead of switches

How dogs may help fight bone cancer

MIT Tech Review gene therapy

Care in Transition Event

Anaplastic Astrocytoma

dysembryoplastic neuroepithelial tumors DNET

Dana-Farber/Boston Children's again named a top national pediatric cancer program

Novel CRISPR-Cas9 genetic screening approach enables discovery of new drug targets to aid cancer immunotherapy

Dana-Farber/Boston Children's responds to FDA approval of CAR-T cell therapy

Gene therapy halts progression of cerebral adrenoleukodystrophy in clinical trial

Two Dana-Farber/Boston Children's faculty members elected to National Academy of Medicine

A new gene therapy transplantation technique could improve treatment of neurodegenerative disease

Bursting with gene therapies and other innovative treatments, the overall survival rate for our blood and marrow transplant patients is exceeding expectations

Dana-Farber/Boston Children’s researcher is part of a new Stand Up To Cancer campaign with Marvel Studios’ Avengers and American Airlines

Endocrine-Oncology Program

Pioneering hematologist to receive 2018 Nemmers Prize in Medical Science

Dana-Farber/Boston Children's again ranked among the top national pediatric cancer programs

Vietnamese boy thrives after gene therapy for Wiskott-Aldrich syndrome

The space between heartache and happiness: Two sons with adrenoleukodystrophy and a gene therapy clinical trial

New gene therapy clinical trial offers hope for sickle cell disease

America is great at beating childhood cancer and it’s about to get better

What the cancer moonshot might mean for kids

Dana-Farber/Boston Children's named a top pediatric cancer program

Leslie Kean, MD, PhD, joins Dana-Farber/Boston Children's Stem Cell Transplantation program

Ocular Oncology Service

Expertise

Clinical Training

International Patient Services

Back to School Support

Referrals and Second Opinions

Become a Patient

Our Brain Tumor Specialists

Insurance and Financial Information

Participating in Clinical Trials

Our Treatment Team

Research and Training

Resource Centers

Clinical Trials & Research

Sibling Program

Five Things Parents Should Know

How to Apply

Preparing for Your First Visit

Continuing Medical Education

Types of Solid Tumors

Programs

Childhood Leukemia, Lymphoma, and Histiocytosis

Types of Brain Tumors

Programs

Our Facilities

Our Fellowship Program

MyChildren's Patient Portal

Our eNewsletter

Research & Innovation

Leadership

Patient & Family Advisory Council

Brain Tumor Survivorship

Patient and Family Support Services

Affiliations and Consortia

Consultations and Second Opinions

Fellows of 2014

Childhood Cancer Awareness Month

Global Health Initiative

International Society of Paediatric Oncology (SIOP) - 2020

History and Milestones

2017 Pediatric Hematology/Oncology Fellows

Flexibility and Special Programs

World-class Childhood Cancer Care

Fellowship Program Leadership

Clinical Trials for Childhood Cancer and Blood Disorders

Diversity and Inclusion

Sickle Cell Disease Treatment for Children

Carlie is More Than You See

Dylan is More Than You See

Carter climbs to new heights after rotationplasty

Teaghan swims through leukemia treatment

Why Choose Us

Innovative Approaches

Sitemap